Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Event Logistics

Video: Immuno-oncology therapies

Immuno-oncology therapies which harness the body’s own defences to fight off tumours are widely acknowledged as the new frontier in cancer treatment. However, these therapies come with a very high price...

Inizio

The challenges of conducting effective pharmaceutical market research in emerging markets

Published in Quirk's Marketing Research Review, April 2016, By Marc Yates, Director of Emerging Markets

Inizio

Bristol-Myers Squibb (BMS) building

Bristol-Myers Squibb acquires Cormorant for $520m

Deal with Swedish firm will boost BMS' oncology pipeline

EU flag

EC approves Bial’s Parkinson’s disease therapy

Ongentys will be given a phase roll-out in 2016 and 2017

- PMLiVE

David Paragamian joins Razorfish Health

He becomes managing director of the Publicis Health agency

- PMLiVE

Packer Forbes acquired by Four Communications

Will rebrand as Four Health Communications

- PMLiVE

Pfizer set to snap up Bind’s assets for $20m

Biotech approves 'stalking horse' bid from the pharma giant

- PMLiVE

Cuttsy and Cuttsy launches campaign celebrating healthcare industry

Encourages people to share positive experiences online

Bristol-Myers Squibb (BMS) building

NICE ‘no’ for Opdivo in kidney cancer

BMS oncology drug knocked-back in draft guidance

Novartis plots digital transformation in medical education

Outlines benefits of greater use of technology, including transparency and reach

Acorda Therapeutics appoints chief medical officer

Interim CMO Dr Burkhard Blank takes on the post in a permanent capacity

- PMLiVE

Amgen’s Kyprolis wins new indication in Europe

Regulators have handed the treatment a less restrictive licence in multiple myeloma 

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links